Search
Now showing items 61-70 of 112
Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology
(Wiley, 2018-05-27)
[Abstract] This article updates the Heart Failure Association of the European Society of Cardiology (ESC) 2007 classification of advanced heart failure and describes new diagnostic and treatment options for these patients. ...
An integrated molecular diagnostic report for heart transplant biopsies using an ensemble of diagnostic algorithms
(Elsevier, 2019-02-06)
[Abstract] BACKGROUND. We previously reported a microarray-based diagnostic system for heart transplant endomyocardial biopsies (EMBs), using either 3-archetype (3AA) or 4-archetype (4AA) unsupervised algorithms to estimate ...
Health‐related quality of life, social support, and caregiver burden between six and 120 months after heart transplantation: a Spanish multicenter cross‐sectional study
(Wiley, 2015-06-15)
[Abstract] A multicenter cross-sectional study was conducted to determine the current heart transplant (HTx) outcomes in Spain. Clinical and functional status, health-related quality of life (HRQoL), social support, and ...
Association between diabetes and 1-year adverse clinical outcomes in a multinational cohort of ambulatory patients with chronic heart failure: results from the ESC-HFA Heart Failure Long-Term Registry
(American Diabetes Association, 2017-03-02)
[Abstract] OBJECTIVE: Diabetes mellitus is associated with an increased risk of cardiovascular disease (CVD) and death. Because the prevalence of diabetes is rising worldwide and chronic heart failure (CHF) is becoming ...
Cancer incidence in heart transplant recipients with previous neoplasia history
(Wiley, 2016-02-03)
[Abstract] Neoplasm history increases morbidity and mortality after solid organ transplantation and has disqualified patients from transplantation. Studies are needed to identify factors to be considered when deciding on ...
Safety of statins when response is carefully monitored: a study of 336 heart recipients
(Elsevier, 2005)
[Abstract] Background. Statins are used as first-line drugs against hypercholesterolemia after heart transplantation. Randomized clinical trials have shown that they reduce cholesterol levels, and the incidence of rejection ...
Renal dysfunction after orthotopic heart transplantation: incidence, natural history, and risk factors
(Elsevier, 2003-08-30)
[Abstract] Background. Renal dysfunction is a common complication after orthotopic heart transplantation (HT). The importance of factors other than exposure to immunosuppressive drugs is unclear. The purpose of this study ...
Effect of a training program for primary care physicians on the optimization of beta-blocker treatment in elderly patients with heart failure
(Elsevier, 2010)
[Abstract] Introduction and objectives. Underuse of beta-blockers may contribute to elevated mortality in chronic heart failure. The aim of this study was to determine whether a specific interventional training program for ...
Differences in outcome of heart failure with preserved or depressed systolic function in patients older than 70 years who receive beta blockers
(Elsevier, 2011-10-14)
[Abstract] Introduction and objectives. Most studies have shown that prognosis of heart failure with preserved systolic function is as poor as that of heart failure with depressed systolic function, although these results ...
Prevalence and severity of renal dysfunction among 1062 heart transplant patients according to criteria based on serum creatinine and estimated glomerular filtration rate: results from the CAPRI study
(Wiley, 2009-12-18)
[Abstract] Chronic kidney disease (CKD) is staged on the basis of glomerular filtration rate; generally, the MDRD study estimate, eGFR, is used. Renal dysfunction (RD) in heart transplant (HT) patients is often evaluated ...
